{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:13:31Z","timestamp":1776687211714,"version":"3.51.2"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s13311-023-01355-7","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T10:03:37Z","timestamp":1678269817000},"page":"767-778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Deepika","family":"Negi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Granak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Shorter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie B.","family":"O'Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Rektor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-4159","authenticated-orcid":false,"given":"Saak V.","family":"Ovsepian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01355-7_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrn1886","article-title":"Ageing and neuronal vulnerability","volume":"7","author":"Mattson","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-023-01355-7_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuron.2011.06.031","article-title":"Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration","volume":"71","author":"Saxena","year":"2011","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01355-7_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib4","first-page":"e105","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019, Lancet","volume":"7","author":"G.B.D.D.F. Collaborators","year":"2022","journal-title":"Public Health"},{"key":"10.1007\/s13311-023-01355-7_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","article-title":"Solving neurodegeneration: common mechanisms and strategies for new treatments","volume":"17","author":"Wareham","year":"2022","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01355-7_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13195-020-00612-7","article-title":"Imaging biomarkers in neurodegeneration: current and future practices","volume":"12","author":"Young","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1007\/s13311-023-01355-7_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuron.2017.10.022","article-title":"Pushing the boundaries of neuroimaging with optoacoustics","volume":"96","author":"Ovsepian","year":"2017","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01355-7_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuroimage.2018.05.050","article-title":"Functional MRI of brain physiology in aging and neurodegenerative diseases","volume":"187","author":"Chen","year":"2019","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01355-7_bib9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.clinph.2020.03.031","article-title":"Human brain connectivity: clinical applications for clinical neurophysiology","volume":"131","author":"Hallett","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1007\/s13311-023-01355-7_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nicl.2016.02.019","article-title":"Differential diagnosis of neurodegenerative diseases using structural MRI data","volume":"11","author":"Koikkalainen","year":"2016","journal-title":"Neuroimage Clin"},{"key":"10.1007\/s13311-023-01355-7_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/alzrt47","article-title":"Role of structural MRI in Alzheimer's disease","volume":"2","author":"Vemuri","year":"2010","journal-title":"Alzheimers Res Ther"},{"key":"10.1007\/s13311-023-01355-7_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/brain\/awm021","article-title":"Rates of cerebral atrophy differ in different degenerative pathologies","volume":"130","author":"Whitwell","year":"2007","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01355-7_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/alzrt248","article-title":"Neuroimaging characteristics of dementia with Lewy bodies","volume":"6","author":"Mak","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1007\/s13311-023-01355-7_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neurobiolaging.2019.09.008","article-title":"What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons","volume":"85","author":"Babiloni","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-023-01355-7_bib17","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clinph.2004.01.001","article-title":"EEG dynamics in patients with Alzheimer's disease","volume":"115","author":"Jeong","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1007\/s13311-023-01355-7_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/jnnp-2018-319581","article-title":"Measuring network disruption in neurodegenerative diseases: new approaches using signal analysis","volume":"90","author":"McMackin","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-023-01355-7_bib19","first-page":"11","article-title":"State-of-the-art methods and emerging fluid biomarkers in the diagnostics of dementia\u2014a short review and diagnostic algorithm","author":"Solje","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1007\/s13311-023-01355-7_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-021-00430-x","article-title":"Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics","volume":"16","author":"Zetterberg","year":"2021","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01355-7_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.conb.2019.11.019","article-title":"An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead","volume":"61","author":"Simren","year":"2020","journal-title":"Curr Opin Neurobiol"},{"key":"10.1007\/s13311-023-01355-7_bib22","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.7150\/thno.72126","article-title":"Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases","volume":"12","author":"Kocurova","year":"2022","journal-title":"Theranostics"},{"key":"10.1007\/s13311-023-01355-7_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2022.09.019","article-title":"Adult neurogenesis in the gut, homeostatic autoimmunity and neurodegenerative disease biomarkers","author":"Ovsepian","year":"2022","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-023-01355-7_bib24","doi-asserted-by":"crossref","first-page":"109281","DOI":"10.1016\/j.jneumeth.2021.109281","article-title":"The blood biomarkers puzzle\u2014a review of protein biomarkers in neurodegenerative diseases","volume":"361","author":"Barro","year":"2021","journal-title":"J Neurosci Methods"},{"key":"10.1007\/s13311-023-01355-7_bib25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med"},{"key":"10.1007\/s13311-023-01355-7_bib26","first-page":"165","article-title":"PET and SPECT in epilepsy","volume":"33","author":"Setoain","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1007\/s13311-023-01355-7_bib27","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamaneurol.2019.1708","article-title":"Progressive cortical thinning in patients with focal epilepsy","volume":"76","author":"Galovic","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.seizure.2021.05.024","article-title":"Granule cell dispersion is associated with hippocampal neuronal cell loss, initial precipitating injury, and other clinical features in mesial temporal lobe epilepsy and hippocampal sclerosis","volume":"90","author":"Jardim","year":"2021","journal-title":"Seizure."},{"key":"10.1007\/s13311-023-01355-7_bib29","series-title":"Inflammation and Epilepsy: New Vistas. Progress in Inflammation Research","article-title":"Tau protein in drug-resistant epilepsy and cognitive decline","author":"Thom","year":"2021"},{"key":"10.1007\/s13311-023-01355-7_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-020-00586-6","article-title":"Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course\u2014a joint PhD student course at University College London and University of Gothenburg","volume":"12","author":"Obrocki","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1007\/s13311-023-01355-7_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2018.05.007","article-title":"Epilepsy biomarkers\u2014toward etiology and pathology specificity","volume":"123","author":"Pitkanen","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01355-7_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","article-title":"The role of inflammation in the development of epilepsy","volume":"15","author":"Rana","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-023-01355-7_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/epi.16405","article-title":"Cerebrospinal fluid and blood biomarkers of status epilepticus","volume":"61","author":"Hanin","year":"2020","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01355-7_bib34","doi-asserted-by":"crossref","first-page":"105872","DOI":"10.1016\/j.nbd.2022.105872","article-title":"Potential clinical and biochemical markers for the prediction of drug-resistant epilepsy: a literature review","volume":"174","author":"Li","year":"2022","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01355-7_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s40263-020-00764-y","article-title":"Neurobiology, functions, and relevance of excitatory amino acid transporters (EAATs) to treatment of refractory epilepsy","volume":"34","author":"Zaitsev","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1007\/s13311-023-01355-7_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01355-7_bib37","first-page":"10","article-title":"Current biomarkers for Alzheimer's disease: from CSF to blood","author":"Zou","year":"2020","journal-title":"J Pers Med."},{"key":"10.1007\/s13311-023-01355-7_bib38","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma beta-amyloid in Alzheimer's disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01355-7_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2217\/17520363.2.4.363","article-title":"Tau as a biomarker of neurodegenerative diseases","volume":"2","author":"Schraen-Maschke","year":"2008","journal-title":"Biomark Med"},{"key":"10.1007\/s13311-023-01355-7_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbadis.2004.06.020","article-title":"Tau protein as a differential biomarker of tauopathies","volume":"1739","author":"Sergeant","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-023-01355-7_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneurol.2009.316","article-title":"Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults","volume":"67","author":"Stomrud","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","article-title":"Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?","volume":"60","author":"Clark","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","article-title":"Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies","volume":"8","author":"Magalhaes","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1007\/s13311-023-01355-7_bib45","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fneur.2019.01388","article-title":"Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson's disease","volume":"10","author":"Chang","year":"2019","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib46","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS","volume":"2","author":"Menke","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib47","doi-asserted-by":"crossref","first-page":"689938","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-023-01355-7_bib48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-023-01355-7_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14737175.2016.1204234","article-title":"Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease","volume":"17","author":"Lista","year":"2017","journal-title":"Expert Rev Neurother"},{"key":"10.1007\/s13311-023-01355-7_bib50","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3233\/JAD-170368","article-title":"Cerebrospinal fluid neurogranin as a biomarker of neurodegenerative diseases: a cross-sectional study","volume":"59","author":"Lista","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-023-01355-7_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12017-009-8076-z","article-title":"Epileptic seizures in AD patients","volume":"12","author":"Larner","year":"2010","journal-title":"Neuromolecular Med"},{"key":"10.1007\/s13311-023-01355-7_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1684\/epd.2021.1406","article-title":"Epilepsy in neurodegenerative diseases","volume":"24","author":"Neri","year":"2022","journal-title":"Epileptic Disord"},{"key":"10.1007\/s13311-023-01355-7_bib53","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/jgs.17101","article-title":"Systematic review of coexistent epileptic seizures and Alzheimer's disease: Incidence and prevalence","volume":"69","author":"Xu","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s13311-023-01355-7_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ene.15089","article-title":"Seizure prevalence in neurodegenerative diseases-a study of autopsy proven cases","volume":"29","author":"Voglein","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer's disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-150544","article-title":"Neuronal activity and amyloid plaque pathology: an update","volume":"49","author":"Ovsepian","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-023-01355-7_bib57","doi-asserted-by":"crossref","first-page":"e48782","DOI":"10.1371\/journal.pone.0048782","article-title":"Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3xTg-AD mice","volume":"7","author":"Yan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01355-7_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/ADR-200286","article-title":"Temporal lobe epilepsy and Alzheimer's disease: from preclinical to clinical evidence of a strong association","volume":"5","author":"Tombini","year":"2021","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1007\/s13311-023-01355-7_bib59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/01.wnl.0000338626.93425.74","article-title":"Georges Marinesco and the early research in neuropathology","volume":"72","author":"Buda","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01355-7_bib60","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF00294177","article-title":"Senile plaques in temporal lobe epilepsy","volume":"87","author":"Mackenzie","year":"1994","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01355-7_bib61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.46.2.425","article-title":"Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques","volume":"46","author":"Mackenzie","year":"1996","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01355-7_bib62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ene.12336","article-title":"Cerebrospinal fluid biomarkers of beta-amyloid metabolism and neuronal damage in epileptic seizures","volume":"21","author":"Shahim","year":"2014","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1007\/s13311-023-01355-7_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac210","article-title":"CSF biomarkers in patients with epilepsy in Alzheimer's disease: a nation-wide study","volume":"4","author":"Banote","year":"2022","journal-title":"Brain Commun."},{"key":"10.1007\/s13311-023-01355-7_bib64","doi-asserted-by":"crossref","first-page":"623777","DOI":"10.3389\/fneur.2021.623777","article-title":"CSF in epileptic prodromal Alzheimer's Disease: no diagnostic contribution but a pathophysiological one","volume":"12","author":"Cretin","year":"2021","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib65","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.seizure.2009.04.006","article-title":"Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure","volume":"18","author":"Palmio","year":"2009","journal-title":"Seizure"},{"key":"10.1007\/s13311-023-01355-7_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2020.12.009","article-title":"Serum biomarkers of cerebral cellular stress after self-limiting tonic clonic seizures: an exploratory study","volume":"85","author":"Nass","year":"2021","journal-title":"Seizure"},{"key":"10.1007\/s13311-023-01355-7_bib67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2018.09.006","article-title":"Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology","volume":"73","author":"Costa","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-023-01355-7_bib68","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yebeh.2015.04.030","article-title":"Cerebrospinal fluid tau proteins in status epilepticus","volume":"49","author":"Monti","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01355-7_bib69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.yebeh.2019.06.033","article-title":"Increased CSF tau is associated with a higher risk of seizures in patients with Alzheimer's disease","volume":"98","author":"Tabuas-Pereira","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01355-7_bib70","doi-asserted-by":"crossref","first-page":"106520","DOI":"10.1016\/j.yebeh.2019.106520","article-title":"Acute symptomatic seizures and epilepsy after mechanical thrombectomy","volume":"104","author":"Eriksson","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01355-7_bib71","doi-asserted-by":"crossref","first-page":"647428","DOI":"10.3389\/fneur.2021.647428","article-title":"CSF and serum biomarkers of cerebral damage in autoimmune epilepsy","volume":"12","author":"Nass","year":"2021","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2013.02.015","article-title":"Cerebrospinal fluid brain injury biomarkers in children: a multicenter study","volume":"49","author":"Shahim","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib73","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/WNR.0000000000001252","article-title":"Association of cerebrospinal fluid zinc-alpha2-glycoprotein and tau protein with temporal lobe epilepsy and related white matter impairment","volume":"30","author":"Mo","year":"2019","journal-title":"NeuroReport"},{"key":"10.1007\/s13311-023-01355-7_bib74","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2021.08.012","article-title":"Brain injury markers in new-onset seizures in adults: A pilot study","volume":"92","author":"Eriksson","year":"2021","journal-title":"Seizure"},{"key":"10.1007\/s13311-023-01355-7_bib75","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/epi.17132","article-title":"Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus","volume":"63","author":"Giovannini","year":"2022","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01355-7_bib76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/epi.16742","article-title":"Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug-resistant epilepsy","volume":"62","author":"Ouedraogo","year":"2021","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01355-7_bib77","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00415-021-10642-2","article-title":"Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis","volume":"269","author":"Lardeux","year":"2022","journal-title":"J Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib78","doi-asserted-by":"crossref","first-page":"579958","DOI":"10.3389\/fnins.2020.579958","article-title":"Serum Neurofilament Levels in Children With Febrile Seizures and in Controls","volume":"14","author":"Evers","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-023-01355-7_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2012.07.043","article-title":"Serum neurofilament concentrations in children with prolonged febrile seizures","volume":"321","author":"Matsushige","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-023-01355-7_bib80","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1038\/srep11135","article-title":"Neurogranin regulates CaM dynamics at dendritic spines","volume":"5","author":"Petersen","year":"2015","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01355-7_bib81","doi-asserted-by":"crossref","first-page":"11232","DOI":"10.1073\/pnas.210184697","article-title":"Involvement of neurogranin in the modulation of calcium\/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice","volume":"97","author":"Pak","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01355-7_bib82","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajem.2022.02.010","article-title":"A new biomarker in the differential diagnosis of epileptic seizure: Neurogranin","volume":"54","author":"Kalkan","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1007\/s13311-023-01355-7_bib83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.seizure.2015.02.007","article-title":"Alpha-synuclein is a potential biomarker in the serum and CSF of patients with intractable epilepsy","volume":"27","author":"Rong","year":"2015","journal-title":"Seizure"},{"key":"10.1007\/s13311-023-01355-7_bib84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12883-020-01662-y","article-title":"Serum alpha-synuclein and IL-1beta are increased and correlated with measures of disease severity in children with epilepsy: potential prognostic biomarkers?","volume":"20","author":"Choi","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1139\/cjpp-2018-0266","article-title":"Effects of metformin on apoptosis and alpha-synuclein in a rat model of pentylenetetrazole-induced epilepsy","volume":"97","author":"Hussein","year":"2019","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1007\/s13311-023-01355-7_bib86","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/brain\/awaa098","article-title":"Neurofilaments: neurobiological foundations for biomarker applications","volume":"143","author":"Gafson","year":"2020","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01355-7_bib87","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/15357597211030385","article-title":"Progressive neuronal loss in epilepsy\u2014a long-standing conundrum finally resolved?","volume":"21","author":"Eid","year":"2021","journal-title":"Epilepsy Curr"},{"key":"10.1007\/s13311-023-01355-7_bib88","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.25005","article-title":"Seizure activity per se does not induce tissue damage markers in human neocortical focal epilepsy","volume":"82","author":"Rossini","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01355-7_bib89","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/brain\/awh475","article-title":"Quantitative post-mortem study of the hippocampus in chronic epilepsy: seizures do not inevitably cause neuronal loss","volume":"128","author":"Thom","year":"2005","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01355-7_bib90","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1528-1157.2003.53902.x","article-title":"Neuronal cell death in a rat model for mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures","volume":"44","author":"Gorter","year":"2003","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-023-01355-7_bib91","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(93)91295-4","article-title":"Morphometric effects of intermittent kindled seizures and limbic status epilepticus in the dentate gyrus of the rat","volume":"603","author":"Bertram","year":"1993","journal-title":"Brain Res"},{"key":"10.1007\/s13311-023-01355-7_bib92","doi-asserted-by":"crossref","first-page":"105183","DOI":"10.1016\/j.nbd.2020.105183","article-title":"Recurrent limbic seizures do not cause hippocampal neuronal loss: A prolonged laboratory study","volume":"148","author":"Mathern","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-023-01355-7_bib93","doi-asserted-by":"crossref","first-page":"19113","DOI":"10.1073\/pnas.1017235108","article-title":"Dendritic SNAREs add a new twist to the old neuron theory","volume":"108","author":"Ovsepian","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01355-7_bib94","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1523\/JNEUROSCI.5490-08.2009","article-title":"Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential","volume":"29","author":"Meng","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01355-7_bib95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuron.2012.09.014","article-title":"Neuropeptide transmission in brain circuits","volume":"76","author":"van den Pol","year":"2012","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01355-7_bib96","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1083\/jcb.200103071","article-title":"Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells","volume":"155","author":"Kleijmeer","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1007\/s13311-023-01355-7_bib97","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pneurobio.2011.01.003","article-title":"Multivesicular bodies in neurons: distribution, protein content, and trafficking functions","volume":"93","author":"Von Bartheld","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-023-01355-7_bib98","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat Med"},{"key":"10.1007\/s13311-023-01355-7_bib99","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fncel.2020.00039","article-title":"Emerging role of the autophagy\/lysosomal degradative pathway in neurodevelopmental disorders with epilepsy","volume":"14","author":"Fassio","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-023-01355-7_bib100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnins.2018.00487","article-title":"Pathological proteins are transported by extracellular vesicles of sporadic amyotrophic lateral sclerosis patients","volume":"12","author":"Sproviero","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-023-01355-7_bib101","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/21541248.2016.1215283","article-title":"Biology and biogenesis of shed microvesicles","volume":"8","author":"Tricarico","year":"2017","journal-title":"Small GTPases"},{"key":"10.1007\/s13311-023-01355-7_bib102","doi-asserted-by":"crossref","first-page":"106499","DOI":"10.1016\/j.yebeh.2019.106499","article-title":"Promise of extracellular vesicles for diagnosis and treatment of epilepsy","volume":"121","author":"Upadhya","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-023-01355-7_bib103","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrn1845","article-title":"Dendritic peptide release and peptide-dependent behaviours","volume":"7","author":"Ludwig","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-023-01355-7_bib104","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00702-014-1312-1","article-title":"The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations","volume":"122","author":"Giorgi","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1007\/s13311-023-01355-7_bib105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-015-0273-8","article-title":"Lymphatic clearance of the brain: perivascular, paravascular and significance for neurodegenerative diseases","volume":"36","author":"Bakker","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"10.1007\/s13311-023-01355-7_bib106","first-page":"F835","article-title":"Drainage of interstitial fluid from different regions of rat brain","volume":"246","author":"Szentistvanyi","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1007\/s13311-023-01355-7_bib107","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10014-016-0255-7","article-title":"Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions","volume":"33","author":"Ueno","year":"2016","journal-title":"Brain Tumor Pathol"},{"key":"10.1007\/s13311-023-01355-7_bib108","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00401-018-1862-7","article-title":"Convective influx\/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways","volume":"136","author":"Albargothy","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01355-7_bib109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","article-title":"Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology","volume":"34","author":"Carare","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1007\/s13311-023-01355-7_bib110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-011-0801-7","article-title":"Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy","volume":"121","author":"Hawkes","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01355-7_bib111","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1007\/s13311-023-01355-7_bib112","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1073858420940943","article-title":"The ups and downs of BACE1: walking a fine line between neurocognitive and other psychiatric symptoms of Alzheimer's disease","volume":"27","author":"Ovsepian","year":"2021","journal-title":"Neuroscientist"},{"key":"10.1007\/s13311-023-01355-7_bib113","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1073858415588264","article-title":"Cholinergic mechanisms in the cerebral cortex: beyond synaptic transmission","volume":"22","author":"Ovsepian","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1007\/s13311-023-01355-7_bib114","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1073858418791128","article-title":"Amyloid plaques of Alzheimer's disease as hotspots of glutamatergic activity","volume":"25","author":"Ovsepian","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1007\/s13311-023-01355-7_bib115","first-page":"4733","article-title":"Ambient glutamate promotes paroxysmal hyperactivity in cortical pyramidal neurons at amyloid plaques via presynaptic mGluR1 receptors","volume":"27","author":"Ovsepian","year":"2017","journal-title":"Cereb Cortex"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01355-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01355-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01355-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:32:34Z","timestamp":1761805954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1878747923000156"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01355-7","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01355-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}